EBF
EBF Focus
Focus
EBF - Focus Workshop
The ‘W4’ of Metabolite profiling and quantification strategies in drug R&D:
When, What, Why and Who?
The Hotel
Brussels, Belgium
25 september 2015

Program

The ‘W4’ of Metabolite profiling and quantification strategies in drug R&D:

When, What, Why and Who?

The program can also be downloaded as a pdf.

24 September 2015
17:00 – 20:00 Registration desk opens
25 September 2015
07.30 – 09.00 Registration desk opens
09.00 – 09.05 Welcome and aim of the meeting
09.05 – 09.30 Scientific and regulatory environment in metabolite profiling and quantification today
(presenter: from EBF), including FB from EBF Survey 
09.30 – 09.55 Preceding scientific drivers and tools to influence metabolic profiling in the regulatory space
(presenter:  Claude Delatour, UCB BioPharma)
09.55 – 10.20 Current practices and future vision on metabolite profiling and quantification in Boehringer-Ingelheim
(presenter: Stefan Blech, Boehringer-Ingelheim)
10.20 – 10.50 Coffee break
10.50 – 11.15 Current practices and future vision on metabolite profiling and quantification in GlaxoSmithKline
(presenter: Graeme Young, GlaxoSmithKline)
11.15 – 11.40 Current practices and future vision on metabolite profiling and quantification in Janssen R&D
(presenter: Geert Mannens, Janssen R&D)
11.40 – 12.10 How to manage metabolite profiling requests from a CRO perspective?
(presenter: Chris Lowrie, Charles River)
12.10 – 13.00 Lunch
13.00 – 15.00 Workshop: towards best practice
13:00 – 13.30 – A ‘best practice’   starting   proposal   (EBF presenter)
13:30 – 15:00 – workshop discussion including multi stakeholder input
(Moderators: presenters from morning sessions)
15.00 – 15.30 Coffee break
15.30 – 16.30 Summary, conclusion and next steps
16:30 Adjourn

 

 

 

 

 

 

__________________________________________________________________________________

Meeting Organisation

Stefan Blech, Boehringer Ingelheim   –    John Smeraglia, UCB –   Steve White, GlaxoSmithKline    –    Stephen Williams, CRL   –    Stuart McDougall, Covance  –    Philip Timmerman, Janssen R&D

The conference is organised as a non-sponsored non-profit event by European Bioanalysis Forum VZW